Trials / Completed
CompletedNCT05914532
New Biomarkers in Axial Sypondyloarthropathy; SII and SIRI
In Patients With Axial Spondyloarthropathy; Evaluation of the Relationship Between the Systemic Immune Inflammation Index and the Systemic Inflammatory Response Index With Disease Activity and Function
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 155 (actual)
- Sponsor
- Istanbul Training and Research Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
investigators aimed to evaluate the relationship between Systemic Immune Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI) and disease activity in patients with axial spondyloarthropathy (SpA).
Detailed description
The clinical characteristics and laboratory data of the patients and healthy controls participating in our study were obtained through the hospital system. Then, the new biomarkers SIRI and SII values were calculated. SIRI= neutrophil count\*monocyte count/lymphocyte count and SII= neutrophil count\*platelet count/lymphocyte count. Then, SIRI and SII values were compared between groups. The relationship between disease activity and SIRI and SII values in the patient group was examined.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | lab testing | Complete blood count and erythrocyte sedimentation rate and C-reactive protein values of the participants were analyzed by laboratory test. |
Timeline
- Start date
- 2023-06-22
- Primary completion
- 2023-07-10
- Completion
- 2023-08-10
- First posted
- 2023-06-22
- Last updated
- 2023-08-23
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05914532. Inclusion in this directory is not an endorsement.